Eric B Farber, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2149 W 24th St, Yuma, AZ 85364 Phone: 928-726-4120 Fax: 928-341-0315 |
Sunil Prakash Deokule, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2149 W 24th St Ste 1, Yuma, AZ 85364 Phone: 928-726-4120 Fax: 928-341-0315 |
Patrick D Aiello, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 275 W. 28th St., Yuma, AZ 85364 Phone: 928-782-1980 Fax: 928-345-2950 |
Jeffrey S Tennant, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 2149 W 24th St, Yuma, AZ 85364 Phone: 928-726-4120 Fax: 928-341-0315 |
Dr. Chaman L Luthra, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2325 S Avenue A, Yuma, AZ 85364 Phone: 928-782-4319 Fax: 928-782-1632 |
Thomas L Podolsky, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1881 W 24th St Ste C, Yuma, AZ 85364 Phone: 928-726-9564 |
News Archive
New research shows that it may be safe for patients taking thyroxine replacement to have low but not suppressed thyroid stimulating hormone (TSH) levels. The research, presented at the Society for Endocrinology BES meeting in Manchester, shows for the first time that it may be safe for patients to take slightly higher doses of thyroxine than are currently recommended.
Scientists at The Scripps Research Institute have found a way to tether HIV-fighting antibodies to immune cells, creating a cell population resistant to the virus.
new Harvey L. Neiman Health Policy Institute study assesses the effect of receiving an Annual Wellness Visit between 2011 and 2013 on the annual rate of eight preventive services recommended for the Medicare population following the AWV.
Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest.
A Yale research team has designed a system to modify, or edit, multiple genes in the genome simultaneously, while also minimizing unintended effects.
› Verified 2 days ago